4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-
Post-operative Seroma Formation
Ittefaq Hospital trustSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Post-operative Seroma Formation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VARINON Ittefaq Hospital trust | Phase 4 | BB |
Artiss Zuyderland Medisch Centrum | Phase 4 | BB |
Tranexamic Acid St. Olavs Hospital | Phase 4 | BB |
Octreotide Pamoate Chemi S.p.A. | Phase 2 | B |
Same molecule, other indications
4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →